Mankind Pharma Agrees to Acquire 70% of Belgium’s ACTx for €48 Million
Mankind Pharma agreed to acquire a 70% stake in Belgium-based Armed Cell Therapeutics for €48 million.
Mankind Pharma has agreed to acquire a 70% stake in Belgium-based biotechnology company Armed Cell Therapeutics (ACTx) for €48 million, marking its entry into next-generation CAR-T cancer therapies as it looks to expand its research and development business globally.The investment will be made thro…